Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a proxy form for its 2026 first class meeting of H shareholders, scheduling the session for 29 May 2026 at 3:30 p.m. (or immediately after the corresponding A-share class meeting) in the company’s headquarters, 38 Chuangye North Road, Jinwan District, Zhuhai, Guangdong Province, China.

The agenda lists one special resolution: granting the Board a general mandate to repurchase the company’s H shares. Shareholders of record may vote in person or by proxy; multiple proxies are permitted provided the share allocation is specified. Valid proxy forms, together with any required notarised authorisations, must reach Tricor Investor Services Limited at least 24 hours before the meeting commences.

Completion of the proxy does not preclude holders from attending and voting in person, whereupon any lodged proxy will be deemed revoked. Joint holders’ voting rights will default to the senior name on the H-share register.

The meeting exclusively targets H-shareholders and will proceed in accordance with Hong Kong Listing Rules, including vote-counting procedures for any abstentions or restricted votes.